Search

Search results

139 results found

Serine/threonine phosphatase PP2A is essential for optimal B cell function

Publication: Journal Article

Meidan, E., H. Li, W. Pan, M. Kono, S. Yu, V. C. Kyttaris, C. Ioannidis, et al. 2020. “Serine/Threonine Phosphatase PP2A Is Essential for Optimal B Cell Function”. JCI Insight 5.

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

Publication: Journal Article

Kost-Alimova, M., E. H. Sidhom, A. Satyam, B. T. Chamberlain, M. Dvela-Levitt, M. Melanson, S. L. Alper, et al. 2020. “A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib As a Candidate for Rapid Repurposing for Acute Lung Injury”. Cell Rep Med 1: 100137.

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections

Publication: Journal Article

Katsuyama, E., A. Suarez-Fueyo, S. J. Bradley, M. Mizui, A. V. Marin, L. Mulki, S. Krishfield, et al. 2020. “The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients With SLE Prone to Infections”. Cell Rep 30: 112-123 e4.

Cancer immunosurveillance by CD8 T cells

Publication: Journal Article

Crispin, J. C., and G. C. Tsokos. 2020. “Cancer Immunosurveillance by CD8 T Cells”. F1000Res 9.

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

Publication: Journal Article

Alimova, M., E. H. Sidhom, A. Satyam, M. Dvela-Levitt, M. Melanson, B. T. Chamberlain, S. L. Alper, et al. 2020. “A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib As a Candidate for Rapid Repurposing for Acute Lung Injury During the COVID-19 Pandemic”. BioRxiv.

My area of expertise is cellular immunology and immunometabolism, focusing on the functions of both murine and human T cells in systemic lupus erythematosus. My long-term goal is to study genetic regulation and cellular metabolism of various cell types as well as the potential treatment during the...

Fatima Alduraibi, MD/PhD

Person: Instructor in Medicine

I am a translational physician-scientist specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE). I initiated my medical career in 2010 and earned my PhD in Immunology from the University of Alabama at Birmingham in 2022. I directs the Autoimmune Skin Diseases Clinic...

Morgane H. Humbel, PhD

Person: Postdoctoral Research Fellow

I am specialized in cellular immunology and have been working in the field of systemic lupus erythematous for 6 years. After finishing my doctorate at the University of Lausanne in Switzerland, I started my work in the Tsokos lab in 2022. Here, I have been dedicating my time on elucidating the role...

Search

Search results

Serine/threonine phosphatase PP2A is essential for optimal B cell function

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections

Cancer immunosurveillance by CD8 T cells

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

Team

Contact

Wei Li, PhD

Fatima Alduraibi, MD/PhD

Morgane H. Humbel, PhD